Trickle Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (1400)	3/27/2003 11:41:25 AM
From: tuck	of 1784

Several Tricklish notes from the Lab Consumer Archives this week . . . Perkin Elmer's new MALDI/TOF featuring orthogonal geometry: the-scientist.com IVGN's new cDNA library construction technology: the-scientist.com ABI's SNPlex system for ultrahigh-throughput genotyping, now in beta testing: the-scientist.com While Drug Discovery & Development looks at the end next steps in whole genome sequencing. This includes the coming demise of the Sanger system, as well as its replacements, including the development by Agilent of a single stranded technology discovered by folks at Harvard, noted here a couple of years ago . . . dddmag.com Also from DD&D, a look at saving time and money in assay development for high-throughput screening: dddmag.com And also, the pros and cons of using animal models for screening and target validation instead of in vitro methods. Mention of LEXG and Xenogen (sentimental favorite) here: dddmag.com Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next